Related Experiment Video

Updated: Sep 9, 2026

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

A note on platelet adhesiveness in ischaemic heart disease

P J NESTEL

    Journal of Clinical Pathology
    |March 1, 1961
    PubMed

    Insights

    Platelet adhesiveness in patients with ischemic heart disease differs based on anticoagulant choice. Sodium citrate revealed higher platelet activity in these patients compared to healthy subjects, unlike EDTA.

    Area of Science:

    • Cardiovascular Science
    • Hematology
    • Clinical Pathology

    Background:

    • Ischemic heart disease (IHD) poses a significant global health burden.
    • Understanding platelet function is crucial for managing IHD.
    • Platelet adhesiveness assays are used to assess thrombotic risk.

    Purpose of the Study:

    • To investigate platelet adhesiveness in IHD patients versus healthy controls.
    • To evaluate the impact of different anticoagulants (EDTA and sodium citrate) on platelet adhesiveness measurements.
    • To determine if anticoagulant choice influences the detection of altered platelet function in IHD.

    Main Methods:

    • In vitro measurement of platelet adhesiveness.
    • Comparison between patients with ischemic heart disease and matched healthy subjects.
    • Utilized two anticoagulants: 1% ethylenediaminetetraacetic acid (EDTA) and 3.8% sodium citrate.

    Main Results:

    • Platelet adhesiveness was significantly higher in IHD patients when using sodium citrate.
    • No significant difference in platelet adhesiveness was observed between IHD patients and controls when using EDTA.
    • Both IHD patients and healthy subjects exhibited significantly greater platelet adhesiveness with sodium citrate compared to EDTA.

    Conclusions:

    • The choice of anticoagulant significantly affects platelet adhesiveness measurements.
    • Sodium citrate may unmask altered platelet adhesiveness in ischemic heart disease patients.
    • EDTA appears to be a more suitable anticoagulant for assessing baseline platelet adhesiveness without confounding effects in IHD studies.

    Keywords:
    BLOOD PLATELETSMYOCARDIAL INFARCT/blood

    More Related Videos

    Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets08:50

    Laminar Flow-based Assays to Investigate Leukocyte Recruitment on Cultured Vascular Cells and Adherent Platelets

    Published on: April 9, 2018

    Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells10:10

    Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

    Published on: October 27, 2009

    Related Concept Videos

    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Intracellular Signaling Affects Focal Adhesions01:17

    Intracellular Signaling Affects Focal Adhesions

    Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
    Some...
    Introduction to Hemostasis01:05

    Introduction to Hemostasis

    Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
    The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Structure and Function of Platelets01:18

    Structure and Function of Platelets

    The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
    Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...